Paricalcitol
- CAS No.
- 131918-61-1
- Chemical Name:
- Paricalcitol
- Synonyms
- Zemplar;CS-1390;Zemplarr;PARICALCITOL;Paricalciferol;D6-Paricalcitol;Paricalcitol, >=98%;Paricalcitol(Zemplar);19-Nor-1,25- dihydroxyvitaMin D2;1α,25-Dihydroxy-19-nor-vitaMin D2
- CBNumber:
- CB0500520
- Molecular Formula:
- C27H44O3
- Molecular Weight:
- 416.65
- MDL Number:
- MOL File:
- 131918-61-1.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Paricalcitol | 1499414 | 3ml | $924 |
| Paricalcitol | 1499403 | 10mg | $3910 |
| Paricalcitol ≥98% | 17716 | 500μg | $98 |
| Paricalcitol ≥98% | 17716 | 1mg | $186 |
| Paricalcitol ≥98% | 17716 | 5mg | $778 |
| More product size | |||
| Boiling point | 564.8±50.0 °C(Predicted) |
|---|---|
| Density | 1.121±0.06 g/cm3(Predicted) |
| Flash point | 14℃ |
| storage temp. | Store at -20°C,unstable in solution, ready to use. |
| solubility | DMSO : 100 mg/mL (240.02 mM; Need ultrasonic)Ethanol : 12.5 mg/mL (30.00 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
| form | Solid |
| pka | 14.34±0.40(Predicted) |
| color | White to off-white |
| InChIKey | BPKAHTKRCLCHEA-UBFJEZKGSA-N |
| SMILES | C[C@]12CCC/C(=C\C=C3C[C@@H](O)C[C@H](O)C3)/[C@]1([H])CC[C@]2([H])[C@H](C)/C=C/[C@H](C)C(O)(C)C |&1:1,10,13,16,20,22,26,r| |
| CAS DataBase Reference | 131918-61-1(CAS DataBase Reference) |
| FDA UNII | 6702D36OG5 |
| NCI Dictionary of Cancer Terms | paricalcitol |
| NCI Drug Dictionary | paricalcitol |
| ATC code | H05BX02 |
| UNSPSC Code | 41116107 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H301+H311-H330-H372 | |||||||||
| Precautionary statements | P280-P301+P310+P330-P302+P352+P312-P304+P340+P310-P314 | |||||||||
| RIDADR | UN1170 - class 3 - PG 2 - Ethanol, solution | |||||||||
| WGK Germany | WGK 3 | |||||||||
| HS Code | 2936299055 | |||||||||
| Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2 very toxic hazardous materials |
|||||||||
| Hazard Classifications | Acute Tox. 2 Inhalation Acute Tox. 3 Dermal Acute Tox. 3 Oral STOT RE 1 Oral |
|||||||||
| Hazardous Substances Data | 131918-61-1(Hazardous Substances Data) | |||||||||
| NFPA 704 |
|
Paricalcitol price More Price(27)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 1499414 | Paricalcitol | 131918-61-1 | 3ml | $924 | 2025-07-31 | Buy |
| Sigma-Aldrich | 1499403 | Paricalcitol | 131918-61-1 | 10mg | $3910 | 2025-07-31 | Buy |
| Cayman Chemical | 17716 | Paricalcitol ≥98% | 131918-61-1 | 500μg | $98 | 2024-03-01 | Buy |
| Cayman Chemical | 17716 | Paricalcitol ≥98% | 131918-61-1 | 1mg | $186 | 2024-03-01 | Buy |
| Cayman Chemical | 17716 | Paricalcitol ≥98% | 131918-61-1 | 5mg | $778 | 2024-03-01 | Buy |
Paricalcitol Chemical Properties,Uses,Production
Description
Paricalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo.
Description
Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.
Chemical Properties
White Solid
Originator
Abbott (US)
Uses
Antihyperparathyriod
Uses
1,25-Dihydroxy vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.
Uses
Synthetic analog of vitamin D. Antihyperparathyroid.
Definition
ChEBI: Paricalcitol is a seco-cholestane and a hydroxy seco-steroid. It has a role as an antiparathyroid drug. It is functionally related to a vitamin D2.
brand name
Zemplar (Abbott).
Clinical Use
Vitamin D analogue:
Treatment and prevention of secondary
hyperparathyroidism associated with chronic renal
failure
Metabolism
Extensively metabolised via hepatic and non-hepatic
pathways to form two relatively inactive metabolites.
After oral administration of 3
H-paricalcitol, only about
2% of the dose was eliminated unchanged in the faeces,
and no parent drug found in the urine.
Approximately
70% of the radioactivity was eliminated in the faeces and
18% was recovered in the urine. Most of the systemic
exposure was from the parent drug.
References
[1] ALEX J BROWN. Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment.[J]. Journal of The American Society of Nephrology, 2000, 11 11: 2088-2094. DOI: 10.1681/asn.v11112088
[2] JAVIER DONATE-CORREA. Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease.[J]. Current drug targets, 2014, 15 7: 703-709. DOI: 10.2174/1389450115666140417120902
[3] MYLES WOLF Ravi T. Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward[J]. Journal of Steroid Biochemistry and Molecular Biology, 2007, 103 3: Pages 487-490. DOI: 10.1016/j.jsbmb.2006.11.009
[4] DARKO DUPLANCIC. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.[J]. Clinical Interventions in Aging, 2013, 8: 149-156. DOI: 10.2147/cia.s38349
Paricalcitol Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| airuikechemical co., ltd. | +86-18353166132 | sales02@airuikechemical.com | China | 983 | 58 |
| HangZhou RunYan Pharma Technology Co.,LTD. | +8618882027439 | sales2@runyanpharma.com | China | 302 | 58 |
| Capot Chemical Co.,Ltd. | +86-(0)57185586718; +8613336195806 | sales@capot.com | China | 29735 | 60 |
| Shanghai Daken Advanced Materials Co.,Ltd | +86-2158073036 | info@dakenam.com | China | 13822 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21595 | 55 |
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3619 | 58 |
| Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 965 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49977 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29795 | 58 |
View Lastest Price from Paricalcitol manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-03-13 | Paricalcitol
131918-61-1
|
US $147.00-745.00 / mg | 99.84% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-08-21 | Paricalcitol
131918-61-1
|
US $0.00-0.00 / g | 1g | 99.0%min. HPLC | 10000 | HangZhou RunYan Pharma Technology Co.,LTD. | |
![]() |
2024-12-24 | Paricalcitol
131918-61-1
|
US $0.00-0.00 / Kg | 1Kg | 99.9% | 20tons | airuikechemical co., ltd. |
-

- Paricalcitol
131918-61-1
- US $147.00-745.00 / mg
- 99.84%
- TargetMol Chemicals Inc.
-

- Paricalcitol
131918-61-1
- US $0.00-0.00 / g
- 99.0%min. HPLC
- HangZhou RunYan Pharma Technology Co.,LTD.
-

- Paricalcitol
131918-61-1
- US $0.00-0.00 / Kg
- 99.9%
- airuikechemical co., ltd.
131918-61-1(Paricalcitol)Related Search:
1of4






